Fintel cuts target for Regis Healthcare stock to AUD 6.20
Published on 10/07/2026 at 05:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Fintel cut the average one-year target for Regis Healthcare stock from AUD 7.59 to AUD 6.20 on September 15, 2026. The revision puts valuation back at the center of the debate after the Australian aged-care operator reported stronger FY2026 operating figures.
Target falls after strong results
According to Fintel on September 15, 2026, the consensus target fell 18.37 percent from AUD 7.59 to AUD 6.20. The same report placed individual targets between AUD 5.05 and AUD 7.77, showing a wide range of views even as the average remained above the latest cited Australian-market close.
The target cut contrasts with Regis Healthcare's FY2026 results. The company's revenue from services increased 16 percent year over year to AUD 1.35 billion, while underlying EBITDA rose 10 percent to AUD 138 million, according to the Yahoo Finance transcript of the August 24, 2026 results call.
Cash flow supports expansion
Regis also reported underlying net profit after tax of AUD 55 million for FY2026, up 4 percent, and net operating cash flow of AUD 336 million, up 10 percent. Net refundable accommodation deposit cash inflows increased 28 percent to AUD 250 million, giving the company an important funding channel for new homes and portfolio investment.
The operating picture includes a cost challenge. Staff costs increased 19 percent to more than AUD 1 billion in FY2026, while management said the business expects staff costs to remain near 78 percent of revenue if funding changes have a neutral effect, the Yahoo Finance transcript shows.
Funding change enters the model
On September 3, 2026, Regis acknowledged an Australian Government increase of 2.55 percent in the Australian National Aged Care Classification starting price to AUD 303.19, effective October 1, 2026, according to Veye. That change matters because management has identified government funding and resident-funded revenue as key drivers of future margin protection.
Veye also reported FY2026 average occupancy of 96 percent and total occupied bed days of 2.85 million. TradingView lists February 23, 2027 as the next earnings date for the company, providing the next scheduled checkpoint for investors.
Regis stock faces a valuation reset
Regis Healthcare is listed on the ASX under REG.AX and ISIN AU000000REG6, according to Global Banking and Finance Review. The company had a market capitalization of AUD 1.3 billion as of October 7, 2026, while its recent FY2026 figures show a business generating cash for acquisitions, construction and dividends.
The latest Lang & Schwarz data set lists a prior close of EUR 2.68 dated October 5, 2026. The further course of trading is shown by the continuously updated real-time quote of Regis Healthcare stock.
Regis Healthcare stock facts
- Company: Regis Healthcare Limited
- ISIN: AU000000REG6
- Ticker: REG.AX
- Primary exchange: ASX
- Prior close Lang & Schwarz (October 5, 2026): EUR 2.68
- Market capitalization: AUD 1.3 billion (as of October 7, 2026)
- Sector / Industry: Healthcare / Medical Care Facilities
- Next earnings date: February 23, 2027
